VOYA INVESTMENT MANAGEMENT LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 135 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.57 and the average weighting 1.1%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$236,000
+3.5%
4,774
+6.6%
0.00%
Q4 2021$228,000
-4.6%
4,477
+4.5%
0.00%
Q3 2021$239,000
-29.7%
4,285
-47.4%
0.00%
-100.0%
Q1 2021$340,000
+0.3%
8,139
+11.9%
0.00%0.0%
Q4 2020$339,000
+10.4%
7,271
+0.6%
0.00%0.0%
Q3 2020$307,000
-12.3%
7,227
-1.0%
0.00%0.0%
Q2 2020$350,000
-7.9%
7,298
-11.7%
0.00%0.0%
Q1 2020$380,000
-52.9%
8,266
-38.5%
0.00%
-50.0%
Q4 2019$807,000
+7.3%
13,437
+1.0%
0.00%0.0%
Q3 2019$752,000
+53.2%
13,302
+50.7%
0.00%
+100.0%
Q2 2019$491,000
+127.3%
8,825
+106.3%
0.00%
Q1 2019$216,000
-22.6%
4,278
+6.2%
0.00%
-100.0%
Q3 2018$279,000
-8.5%
4,0300.0%0.00%0.0%
Q2 2018$305,000
+21.5%
4,030
-4.1%
0.00%0.0%
Q3 2017$251,000
-24.4%
4,2040.0%0.00%0.0%
Q2 2017$332,000
+13.3%
4,204
+19.1%
0.00%0.0%
Q1 2017$293,000
+4.6%
3,5290.0%0.00%0.0%
Q4 2016$280,000
-3.1%
3,529
-14.4%
0.00%0.0%
Q3 2016$289,000
-8.5%
4,122
+15.5%
0.00%0.0%
Q4 2015$316,000
+19.7%
3,5680.0%0.00%0.0%
Q3 2015$264,000
-21.7%
3,568
-14.5%
0.00%0.0%
Q2 2015$337,0004,1710.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 112,666$1,7770.65%
Smith, Graham & Co., Investment Advisors, LP 273,099$4,306,7710.54%
BRANDES INVESTMENT PARTNERS, LP 1,134,363$17,888,9040.35%
TANG CAPITAL MANAGEMENT LLC 118,857$1,874,3750.26%
Virtus Investment Advisers, Inc. 20,867$329,0730.22%
DENALI ADVISORS LLC 32,300$509,3710.18%
Nebula Research & Development LLC 11,473$180,9290.10%
SCOUT INVESTMENTS, INC. 131,192$1,995,4300.05%
XTX Topco Ltd 15,050$237,3390.04%
PDT Partners, LLC 19,745$311,3790.04%
View complete list of EAGLE PHARMACEUTICALS INC shareholders